Quemliclustat and chemotherapy with or without zimberelimab in metastatic pancreatic adenocarcinoma: a randomized phase 1 trial

Journal:
Nature Medicine
Published:
Affiliations:
15
Authors:
24
Institutions Authors Share
Arcus Biosciences, United States of America (USA)
13.000000
13.000000
0.54
UCLA Health, United States of America (USA)
1.000000
0.04
Allegheny Health Network (AHN), United States of America (USA)
1.000000
0.04
OU Health Sciences Center (OUHSC), United States of America (USA)
1.000000
0.04
The University of Texas MD Anderson Cancer Center, United States of America (USA)
1.000000
0.04
Sarah Cannon Research Institute (SCRI), United States of America (USA)
1.000000
0.04
NYU Langone Health, United States of America (USA)
1.000000
0.04
University of Pittsburgh Medical Center (UPMC), United States of America (USA)
1.000000
0.04
Medidata Solutions Inc., United States of America (USA)
1.000000
0.04
Columbia University Irving Medical Center (CUIMC), CU, United States of America (USA)
0.500000
0.02
Herbert Irving Comprehensive Cancer Center (HICCC), United States of America (USA)
0.500000
0.02
University of Wisconsin-Madison (UW-Madison), United States of America (USA)
0.500000
0.02
University of Wisconsin Carbone Cancer Center (UWCCC), United States of America (USA)
0.500000
0.02
Memorial Sloan Kettering Cancer Center (MSKCC), United States of America (USA)
0.500000
0.02
Weill Cornell Medicine, United States of America (USA)
0.500000
0.02